Gilead Sciences, Inc. (NASDAQ:GILD)


US-based biopharmaceutical company Gilead Sciences, Inc. (NASDAQ:GILD) is engaged in the development as well as commercialization of innovative medicines for life-threatening diseases having unmet medical need. Primarily, the Company is focused on developing treatments for liver disease, HIV, AIDS, and serious cardiovascular & respiratory ailments.

Similar Companies

Load More
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK